Pretreatment evaluation of prostate cancer: role of MR imaging and 1H MR spectroscopy.
about
Multiscale observation of biological interactions of nanocarriers: from nano to macro.Assessing the validity of Prostate Imaging Reporting and Data System version 2 (PI-RADS v2) scoring system in diagnosis of peripheral zone prostate cancer.A meta-analysis of the accuracy of prostate cancer studies which use magnetic resonance spectroscopy as a diagnostic tool.Are histopathological features of prostate cancer lesions associated with identification of extracapsular extension on magnetic resonance imaging?Incremental value of magnetic resonance imaging in the advanced management of prostate cancer.Prostate MRI and 3D MR spectroscopy: how we do itPerformance of external and internal coil configurations for prostate investigations at 7 T.Diagnosis of relevant prostate cancer using supplementary cores from magnetic resonance imaging-prompted areas following multiple failed biopsies.Multiparametric MRI for recurrent prostate cancer post radical prostatectomy and postradiation therapy.Urovision 2020: The future of urology.False positive and false negative diagnoses of prostate cancer at multi-parametric prostate MRI in active surveillanceComparison of pelvic phased-array versus endorectal coil magnetic resonance imaging at 3 Tesla for local staging of prostate cancer.Imaging techniques for prostate cancer: implications for focal therapyImaging localized prostate cancer: current approaches and new developments.Usefulness of a combined approach of t1-weighted, t2-weighted, dynamic contrast-enhanced, and diffusion-weighted imaging in prostate cancer.Interactive dedicated training curriculum improves accuracy in the interpretation of MR imaging of prostate cancer.Multiparametric magnetic resonance imaging of prostate cancer.Prediction of prostate cancer extracapsular extension with high spatial resolution dynamic contrast-enhanced 3-T MRI.Prostate cancer magnetic resonance imaging (MRI): multidisciplinary standpoint.New horizons in prostate cancer imaging.Stromal prostatic sarcoma: a rare tumor with rare clinical and imaging presentation.Imaging in prostate cancer diagnosis: present role and future perspectives.State-of-the-art uroradiologic imaging in the diagnosis of prostate cancer.Detection and localization of prostate cancer with the targeted biopsy strategy based on ADC map: a prospective large-scale cohort studyMR imaging of the prostate and adjacent anatomic structures before, during, and after ejaculation: qualitative and quantitative evaluation.Interpretation and reporting multiparametric prostate MRI: a primer for residents and novices.Value of preoperative 3T multiparametric MRI for surgical margin status in patients with prostate cancer.Early diagnosis of prostate cancer by citrate determination in urine with europium-oxytetracycline complex.Correlation of Gleason scores with diffusion-weighted imaging findings of prostate cancer.Targeted biopsy based on ADC map in the detection and localization of prostate cancer: a feasibility study.Multi-parametric MR imaging of transition zone prostate cancer: Imaging features, detection and staging.3 Tesla multiparametric MRI for GTV-definition of Dominant Intraprostatic Lesions in patients with Prostate Cancer--an interobserver variability study.Dynamic MRI and CAD vs. choline MRS: where is the detection level for a lesion characterisation in prostate cancer?Multi-parametric (mp) MRI of prostatic ductal adenocarcinoma.Incremental value of high b value diffusion-weighted magnetic resonance imaging at 3-T for prediction of extracapsular extension in patients with prostate cancer: preliminary experience.Investigating the clinical aspects of using CT vs. CT-MRI images during organ delineation and treatment planning in prostate cancer radiotherapy.Prostatic ductal adenocarcinoma: an aggressive tumour variant unrecognized on T2 weighted magnetic resonance imaging (MRI)Picture QuizProstate cancer staging
P2860
Q30474384-ECB585B1-DD5B-4E55-9353-A3537A2661E0Q30843143-4D0D677B-3937-4EB1-9A71-220F9E8F03E2Q33374270-DDAC0403-DF11-4DE7-8357-865BAC6B6C11Q33699276-6976213C-DA19-47BE-90CC-53EE78D05F5EQ33772524-9B4CA180-A56C-4AC1-9158-C4EFD26CB798Q33954515-F8673AC9-5906-455A-9621-43A094182E4EQ34348281-473F4F24-30A8-4391-8492-D0BA6EA9AB84Q34678985-0E14396D-AAED-46B3-8A6B-87AE4E69CB7DQ35195300-5ED3B7F4-0B48-43EB-B1A2-0B021424C043Q35423105-6149AADC-A9EC-42C0-9E5D-69DCE4C9E231Q35902253-4066490C-E08E-44D8-8328-3A5118042ABDQ35932176-0826868F-DC02-4190-A8A5-009C2CC5AD0BQ36460818-2E77B8D0-AB2C-4D2D-88A9-B8812819EE0EQ36469177-5EFFAD02-7094-47AC-B540-82F13A835163Q36492465-40DBF139-02D9-43A1-A864-249C20B5E7A1Q36721080-4DCC00DA-D2A2-4EE6-9640-3A57C4D5C4C1Q36761055-0B098868-A40E-4FA9-8FA4-60FCECAB2E49Q36792155-40881762-495B-44C5-9B6D-3451AF336076Q36795496-11F6D8FB-7A67-4FAB-A0AE-C673DDB43AB9Q37242030-07E23440-AA04-4C4E-81CD-7862DC4059A9Q37463428-33E66A9A-65D0-40A0-B71E-3ECE32ED02BAQ37849513-327728A8-D514-483F-BE5C-193F0F190657Q37878465-FD71BC7D-5FC4-4393-9829-BA5CEE719EA2Q37975995-831454FB-6FCC-4AB3-835D-6CDCF069D685Q38185148-35AA5A7C-212F-47FE-90D4-F86A1B408206Q38190885-627AE8AD-2317-476C-81E8-50D1AB6789BAQ38731500-3551CE83-A04D-41F1-B3C3-26706E2BF3F2Q39313646-1FAEC9B6-9527-49B2-BFEB-A0504CA11EB5Q39998299-59FF2DC0-6C43-43D7-B6E2-A6E18D3A8B2FQ41058922-A3FC308A-17A0-4FDA-BC28-CB0C0D6287C6Q41138148-F8DBF775-CB51-4B99-A8FA-7A75628FBF2FQ42906342-BA217F0E-15D1-4F13-BA39-0D506B72ED02Q43287327-E19F5D86-CDA5-412B-B57A-8B072E22B243Q44776478-4FAA6BFB-72FA-4A89-B1BA-8A69428AE6D9Q51272974-5F871ADE-01DE-4E87-865C-59B6CD7CD4D9Q51576010-5748FD76-F09E-4A2F-909A-E68D6CC15983Q57101049-82D15324-B217-4946-A845-ED5E3866FCC5Q57893969-1719FD28-242C-44A1-A9A9-C20D91F36A25Q57893976-97CA156F-5BCC-45DA-B856-0CD0B0419EB2
P2860
Pretreatment evaluation of prostate cancer: role of MR imaging and 1H MR spectroscopy.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Pretreatment evaluation of prostate cancer: role of MR imaging and 1H MR spectroscopy.
@ast
Pretreatment evaluation of prostate cancer: role of MR imaging and 1H MR spectroscopy.
@en
type
label
Pretreatment evaluation of prostate cancer: role of MR imaging and 1H MR spectroscopy.
@ast
Pretreatment evaluation of prostate cancer: role of MR imaging and 1H MR spectroscopy.
@en
prefLabel
Pretreatment evaluation of prostate cancer: role of MR imaging and 1H MR spectroscopy.
@ast
Pretreatment evaluation of prostate cancer: role of MR imaging and 1H MR spectroscopy.
@en
P2093
P356
P1433
P1476
Pretreatment evaluation of prostate cancer: role of MR imaging and 1H MR spectroscopy.
@en
P2093
Filip G Claus
Hedvig Hricak
Robert R Hattery
P304
P356
10.1148/24SI045516
P478
24 Suppl 1
P577
2004-10-01T00:00:00Z